Cargando…

Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients

BACKGROUND. Early detection of rejection in kidney transplant recipients holds the promise to improve clinical outcomes. Development and implementation of more accurate, noninvasive methods to detect allograft rejection remain an ongoing challenge. The limitations of existing allograft surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altuğ, Yücel, Liang, Nathan, Ram, Rosalyn, Ravi, Harini, Ahmed, Ebad, Brevnov, Maxim, Swenerton, Ryan K., Zimmermann, Bernhard, Malhotra, Meenakshi, Demko, Zachary P., Billings, Paul R., Ryan, Allison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Clinical Science—General
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867667/ https://www.ncbi.nlm.nih.gov/pubmed/30801536 http://dx.doi.org/10.1097/TP.0000000000002665

Ejemplares similares

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation
por: Kim, Paul J., et al.
Publicado: (2022)

Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation
por: Ventura-Aguiar, Pedro, et al.
Publicado: (2022)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
por: Hedriana, Herman, et al.
Publicado: (2019)

Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019)

Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples
por: Ravi, Harini, et al.
Publicado: (2018)

Non-Invasive Prenatal Detection of Trisomy 13 Using a Single Nucleotide Polymorphism- and Informatics-Based Approach
por: Hall, Megan P., et al.
Publicado: (2014)

Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy
por: Norwitz, Errol R., et al.
Publicado: (2019)

Clinician‐reported chorionicity and zygosity assignment using single‐nucleotide polymorphism‐based cell‐free DNA: Lessons learned from 55,344 twin pregnancies
por: Wojas, Anna, et al.
Publicado: (2022)

Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
por: Kirkizlar, Eser, et al.
Publicado: (2015)

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
por: Sigdel, Tara K., et al.
Publicado: (2018)

Auto-Rejection of Renal Donor-Origin Metastatic Melanoma
por: Kriegshauser, J. Scott, et al.
Publicado: (2015)

Combining the use of a fetal fraction‐based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy
por: Benn, Peter, et al.
Publicado: (2019)

Endothelial failure and rejection in recipients of corneas from the same donor
por: Downward, Lewis, et al.
Publicado: (2022)

Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection
por: Bunnapradist, Suphamai, et al.
Publicado: (2021)

Selective Recruitment of Large Lower Lobe Atelectasis on Donor Back Table in Rejected Donor Lungs
por: Okamoto, Toshihiro, et al.
Publicado: (2019)

Preventing Rejection of the Kidney Transplant
por: Malhotra, Divyanshu, et al.
Publicado: (2023)

Correction: Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach
por: Westemeyer, Maggie, et al.
Publicado: (2020)

Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach
por: Westemeyer, Maggie, et al.
Publicado: (2020)

Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020)

THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES
por: Oppenheim, Joost J., et al.
Publicado: (1965)

Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
por: Hancock, Wayne W., et al.
Publicado: (2001)

Approaching treatment for immunological rejection of living-donor liver transplantation in rats
por: Feng, Yanhu, et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Plan for blood banks to protect blood donors and healthcare workers during COVID-19 pandemic
por: Ali, Sheikh Muhammad Ebad, et al.
Publicado: (2020)

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.
por: El-Meteini, Mahmoud, et al.
Publicado: (2014)

Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells
por: Ueta, Hisashi, et al.
Publicado: (2020)

Ashwagandha and Kidney Transplant Rejection
por: Sriperumbuduri, Sriram, et al.
Publicado: (2020)

Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection
por: Rosenheck, J.P., et al.
Publicado: (2022)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

T-cell allorecognition of donor glutathione S-transferase T1 in plasma cell-rich rejection
por: Martínez-Bravo, María José, et al.
Publicado: (2017)

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure
por: Parajuli, Sandesh, et al.
Publicado: (2019)

Obstacles to the deceased donor transplantation in Pakistan
por: Ullah, Kaleem, et al.
Publicado: (2023)

Non‐invasive prenatal screening for fetal triploidy using single nucleotide polymorphism‐based testing: Differential diagnosis and clinical management in cases showing an extra haplotype
por: Kantor, Valerie, et al.
Publicado: (2022)

DO THE PSYCHIATRIC PATIENTS REJECT THEMSELVES?
por: Malhotra, H. K., et al.
Publicado: (1981)

Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome
por: Gross, S. J., et al.
Publicado: (2016)

Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation
por: Islam, M. Mirazul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_956rsk0fi85l0tlrjtde6u4hhr